Canada's Leading Collection of Photos & Video | Canadian Press Images - AstraZeneca blood clot risk remains low: Tam

AstraZeneca blood clot risk remains low: Tam

Standard Video

CP121635062 | AstraZeneca vaccine to remain authorized in Canada

CP124397371 | AstraZeneca recipients can get Moderna or Pfizer for second dose: NACI

CP122404571 | Quebec reports first blood clot death in woman who received AstraZeneca vaccine

CP123262421 | N.S. pauses use of AstraZeneca vaccine

CP120476771 | AstraZeneca vaccine's benefits vastly outweigh risks: Sharma

CP123597771 | Second-dose choice likely for AstraZeneca recipients: Tam

CP122830710 | New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine

CP123251321 | Ontario to get more than 250,000 AstraZeneca doses

CP122904771 | B.C. records first case of rare blood clot related to vaccine

CP123597810 | Newsroom Ready: Second-dose choice likely for AstraZeneca recipients: Tam

Country Canada

Type of video?

For editorial use only. Video needs to be used in its entirety (i.e. use of select segment(s) not allowed).

Audience Size

Usage description

AstraZeneca blood clot risk remains low: Tam

Source name:

Unique identifier: CP122017117

Legacy Identifier: n_Tam-NACI-Vaccine20210421T1430

Type: Video

Duration: 3m17s

Dimensions: 1920px × 1080px 143.31 MB

Usage rights: FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.

Create Date: 4/21/2021 2:30:00 PM

Display aspect ratio: 16:9